A novel role for human sulfiredoxin in the reversal of glutathionylation

被引:159
作者
Findlay, Victoria J.
Townsend, Danyelle M.
Morris, Taylor E.
Fraser, Jacob P.
He, Lin
Tew, Kenneth D.
机构
[1] Med Univ S Carolina, Dept Mol & Cellular Pharmacol, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA
关键词
D O I
10.1158/0008-5472.CAN-06-0484
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Modification of protein cysteine residues by disulfide formation with glutathione (glutathionylation) is a reversible posttranslational modification of critical importance in controlling cell signaling events following oxidative and/or nitrosative stress. Here, we show that human sulfiredoxin, a small redox protein conserved in eukaryotes, can act as a novel regulator of the redox-activated thiol switch in cells by catalyzing deglutathionylation of a number of distinct proteins in response to oxidative and/or nitrosative stress. Actin and protein tyrosine phosphatase 1B were identified in vitro as targets of sulfiredoxin I (Srx1)-dependent deglutathionylation and confirmed in vivo by two-dimensional gel electrophoresis analysis. In addition, we show that Srx1-dependent deglutathionylation is functionally relevant through restoration of phosphatase activity. Human sulfiredoxin contains one cysteine residue (Cys(99)) that is conserved in all family members. Mutation of the cysteine residue inhibits deglutathionylation but did not affect its capacity to bind intracellular proteins. Furthermore, sulfiredoxin is not an acceptor molecule for the GS(-) moiety during the reaction process. Using two-dimensional gel electrophoresis, we identified multiple protein targets in vivo that are deglutathionylated by sulfiredoxin following oxidative and/or nitrosative stress. This novel deglutathionylation function of sulfiredoxin suggests it has a central role in redox control with potential implications in cell signaling.
引用
收藏
页码:6800 / 6806
页数:7
相关论文
共 34 条
  • [1] Protein tyrosine phosphatases: the quest for negative regulators of insulin action
    Asante-Appiah, E
    Kennedy, BP
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (04): : E663 - E670
  • [2] Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B
    Barrett, WC
    DeGnore, JP
    Keng, YF
    Zhang, ZY
    Yim, MB
    Chock, PB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (49) : 34543 - 34546
  • [3] Regulation of PTP1B via glutathionylation of the active site cysteine 215
    Barrett, WC
    DeGnore, JP
    König, S
    Fales, HM
    Keng, YF
    Zhang, ZY
    Yim, MB
    Chock, PB
    [J]. BIOCHEMISTRY, 1999, 38 (20) : 6699 - 6705
  • [4] ATP-dependent reduction of cysteine-sulphinic acid by S-cerevisiae sulphiredoxin
    Biteau, B
    Labarre, J
    Toledano, MB
    [J]. NATURE, 2003, 425 (6961) : 980 - 984
  • [5] Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine
    Chang, TS
    Jeong, W
    Woo, HA
    Lee, SM
    Park, S
    Rhee, SG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (49) : 50994 - 51001
  • [6] Oxidative stress inhibits MEKK1 by site-specific glutathionylation in the ATP-binding domain
    Cross, JV
    Templeton, DJ
    [J]. BIOCHEMICAL JOURNAL, 2004, 381 (03) : 675 - 683
  • [7] Protein S-thiolation and regulation of microsomal glutathione transferase activity by the glutathione redox couple
    Dafre, AL
    Sies, H
    Akerboom, T
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 332 (02) : 288 - 294
  • [8] Proteins as biomarkers of oxidative/nitrosative stress in diseases: The contribution of redox proteomics
    Dalle-Donne, I
    Scaloni, A
    Giustarini, D
    Cavarra, E
    Tell, G
    Lungarella, G
    Colombo, R
    Rossi, R
    Milzani, A
    [J]. MASS SPECTROMETRY REVIEWS, 2005, 24 (01) : 55 - 99
  • [9] Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug
    Findlay, VJ
    Townsend, DM
    Saavedra, JE
    Buzard, GS
    Citro, ML
    Keefer, LK
    Ji, XH
    Tew, KD
    [J]. MOLECULAR PHARMACOLOGY, 2004, 65 (05) : 1070 - 1079
  • [10] GILBERT HF, 1995, METHOD ENZYMOL, V251, P8, DOI 10.1016/0076-6879(95)51107-5